EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Impact of obesity on catheter ablation of atrial fibrillation: Patient characteristics, procedural complications, outcomes, and quality of life

Chadi Tabaja iD, Arwa Younis, Pasquale Santageli, Medhat Farwati iD, Lorenzo Braghieri, Hiroshi Nakagawa, Walid I Saliba, Ruth Madden, Patricia Bouscher, Mohamed Kanj, Thomas D Callahan iD, David Martin und 9 weitere

Journal of Cardiovascular Electrophysiology · 2023-08 · 34 (8) · 1648-1657

DOI: 10.1111/jce.15987 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 26.07.2023. Verfasst von Chadi Tabaja und 20 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiac Pacing and Electrophysiology, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: BLRD VA, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Obesity is a well‐known risk factor for atrial fibrillation (AF). We aim to evaluate the effect of baseline obesity on procedural complications, AF recurrence, and symptoms following catheter ablation (CA).

Methods

All consecutive patients undergoing AF ablation (2013–2021) at our center were enrolled in a prospective registry. The study included all consecutive patients with available data on body mass index (BMI). Primary endpoint was AF recurrence based on electrocardiographic documentation. Patients were categorized into five groups according to their baseline BMI. Patients survey at baseline and at follow‐up were used to calculate AF symptom severity score (AFSS) as well as AF burden (mean of AF duration score and AF frequency score; scale 0: no AF to 10: continuous and 9 frequencies/durations in between). Patients were scheduled for follow‐up visits with 12‐lead electrocardiogram at 3, 6, and 12 months after ablation, and every 6 months thereafter.

Results

A total of 5841 patients were included (17% normal weight, 34% overweight, 27% Class I, 13% Class II, and 9% Class III obesity). Major procedural complications were low (1.5%) among all BMI subgroups. At 3 years AF recurrence was the highest in Class III obesity patients (48%) followed by Class II (43%), whereas Class I, normal, and overweight had similar results with lower recurrence (35%). In multivariable analyses, Class III obesity (BMI ≥ 40) was independently associated with increased risk for AF recurrence (hazard ratio, 1.30; confidence interval, 1.06–1.60; p = .01), whereas other groups had similar risk in comparison to normal weight. Baseline AFSS was lowest in normal weight, and highest in Obesity‐III, median (interquartile range) 10 (5–16) versus 15 (10–21). In all groups, CA resulted in a significant improvement in their AFSS with a similar magnitude among the groups. At follow‐up, AF burden was minimal and did not differ significantly between the groups.

Conclusion

AF ablation is safe with a low complication rate across all BMI groups. Morbid obesity (BMI ≥ 40) was significantly associated with reduced AF ablation success. However, ablation resulted in improvement in QoL including reduction of the AFSS, and AF burden regardless of BMI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationHumansQuality of LifeOverweightRecurrenceObesityTreatment Outcome

Stichwörter der Autor:innen

atrial fibrillationcatheter ablationobesitypatient reported outcomesquality of life

Autor:innen und Institutionen

  • Section of Cardiac Pacing and Electrophysiology, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.

ORCID-Profile: Chadi Tabaja, Medhat Farwati, Thomas D Callahan, Mina Chung, Shady Nakhla

Förderung

  • BLRD VA
  • NHLBI NIH HHS

Zitieren

APA

Tabaja, C., Younis, A., Santageli, P., Farwati, M., Braghieri, L., Nakagawa, H., Saliba, W. I., Madden, R., Bouscher, P., Kanj, M., Callahan, T. D., Martin, D., Bhargava, M., Chung, M., Baranowski, B., Nakhla, S., Sroubek, J., Lee, J., Taigen, T., …, & Hussein, A. A. (2023). Impact of obesity on catheter ablation of atrial fibrillation: Patient characteristics, procedural complications, outcomes, and quality of life. Journal of Cardiovascular Electrophysiology, 34(8), 1648-1657. https://doi.org/10.1111/jce.15987

Vancouver

Tabaja C, Younis A, Santageli P, Farwati M, Braghieri L, Nakagawa H, et al. Impact of obesity on catheter ablation of atrial fibrillation: Patient characteristics, procedural complications, outcomes, and quality of life. Journal of Cardiovascular Electrophysiology. 2023;34(8):1648-1657. doi:10.1111/jce.15987

BibTeX
@article{Tabaja2023,
  author = {Tabaja, Chadi and Younis, Arwa and Santageli, Pasquale and Farwati, Medhat and Braghieri, Lorenzo and Nakagawa, Hiroshi and Saliba, Walid I and Madden, Ruth and Bouscher, Patricia and Kanj, Mohamed and Callahan, Thomas D and Martin, David and Bhargava, Mandeep and Chung, Mina and Baranowski, Bryan and Nakhla, Shady and Sroubek, Jakub and Lee, Justin and Taigen, Tyler and Wazni, Oussama M and Hussein, Ayman A},
  title = {Impact of obesity on catheter ablation of atrial fibrillation: Patient characteristics, procedural complications, outcomes, and quality of life},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2023},
  volume = {34},
  number = {8},
  pages = {1648--1657},
  doi = {10.1111/jce.15987}
}
Kostenlos starten →